Kekasih Bayangan
By : Cakra Khan
Intro : C G/B A# A Dm G
C G
padamu pemilik
Am Em
hati yang tak pernah ku miliki
F Em Am
yang hadir sebagai
Dm F C G
bagian dari kisah hidupku
C G
engkau aku cinta
Am Em
dengan segenap rasa di hati
F Em Am
selalu ku mencoba
Dm F C
menjadi seperti yang engkau minta
Chorus:
F G
aku tahu engkau sebenarnya tahu
E Am
tapi kau memilih seolah engkau tak tahu
G Dm G
kau sembunyikan rasa cintaku
C C7
di balik topeng persahabatanmu yang palsu
F G
kau jadikan aku kekasih bayangan
E Am
untuk menemani saat kau merasa sepi
G Dm Fm G C
bertahun lamanya kujalani kisah cinta sendiri
C G/B
mungkin memang benar
Am Em
cinta itu tak lagi berharga
F Em Am
semua percuma
Dm F C
bila engkau tak punya ikatan
Chorus:
F G
aku tahu engkau sebenarnya tahu
E Am
tapi kau memilih seolah engkau tak tahu
G Dm G
kau sembunyikan rasa cintaku
C C7
di balik topeng persahabatanmu yang palsu
F G
kau jadikan aku kekasih bayangan
E Am
untuk menemani saat kau merasa sepi
G Dm Fm G C Am Dm
bertahun lamanya kujalani kisah cinta sendiri
G C Am F G
cinta sendiri
Chorus:
F G
aku tahu engkau sebenarnya tahu
E Am
tapi kau memilih seolah engkau tak tahu
G Dm G
kau sembunyikan rasa cintaku
C C7
di balik topeng persahabatanmu yang palsu
F G
kau jadikan aku kekasih bayangan
E Am
untuk menemani saat kau merasa sepi
Dm Fm C Am F
bertahun lamanya kujalani kisah cinta sendiri
G C
cinta sendiri
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment